cannabinoid pharmaceutical : Press Release Distribution

Health Feb 02, 2017

Cannabinoid pharmaceuticals now in development for inflammatory bowel disease and narcotic bowel syndrome, a severe form of opiate-induced a

News Dec 26, 2016

Approval of cannaboside pharmaceutical research included review by FDA and California Research Advisory Panel